These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 7956457
1. Enhanced chemiluminescence response of polymorphonuclear leukocytes by new quinolone antimicrobials. Kubo S, Matsumoto T, Takahashi K, Haraoka M, Tanaka M, Sakumoto M, Sakamoto Y, Kumazawa J. Chemotherapy; 1994; 40(5):333-6. PubMed ID: 7956457 [Abstract] [Full Text] [Related]
2. Effect of newer quinolones on the extra- and intra-cellular chemiluminescence response of human polymorphonuclear leucocytes. Aoki M, Ono Y, Kunii O, Goldstein E. J Antimicrob Chemother; 1994 Sep; 34(3):383-90. PubMed ID: 7829412 [Abstract] [Full Text] [Related]
3. Fleroxacin enhancement of superoxide production by polymorphonuclear leukocytes: the role of protein kinases. Matsumoto T, Takahashi K, Nagafuji T, Kubo S, Sakumoto M, Mochida O, Sakamoto Y, Mizunoe Y, Kumazawa J. Chemotherapy; 1996 Sep; 42(4):280-5. PubMed ID: 8804796 [Abstract] [Full Text] [Related]
4. [In vitro activities of newly developed quinolones, fleroxacin, lomefloxacin and sparfloxacin against Mycobacterium tuberculosis]. Kawahara S, Kamisaka K, Tada A, Nakada H, Mishima Y, Yoshimoto S, Matsuyama T, Kibata M, Nagare J. Kekkaku; 1991 Jun; 66(6):429-31. PubMed ID: 1942726 [Abstract] [Full Text] [Related]
5. Ofloxacin and fleroxacin enhance superoxide production in human polymorphonuclear leukocytes by increasing phosphorylation in the signal transduction pathway. Matsumoto T, Nagafuji T, Takahashi K, Kubo S, Sakumoto M, Mizunoe Y, Kumazawa J. Int J Antimicrob Agents; 1995 Dec; 6(2):85-9. PubMed ID: 18611690 [Abstract] [Full Text] [Related]
6. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents. McCarter YS, Mazens-Sullivan MF, Bartlett RC. Chemotherapy; 1992 Dec; 38(5):308-18. PubMed ID: 1337507 [Abstract] [Full Text] [Related]
10. Effect of inhibitors of protein kinase C on enhanced superoxide production of human leucocytes by ofloxacin and fleroxacin. Matsumoto T, Takahashi K, Nagafuji T, Kubo S, Kumazawa J. Drugs; 1995 Dec; 49 Suppl 2():286-8. PubMed ID: 8549334 [No Abstract] [Full Text] [Related]
11. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers. Beskid G, Prosser BL. Am J Med; 1993 Mar 22; 94(3A):2S-8S. PubMed ID: 8383919 [Abstract] [Full Text] [Related]
12. A multicenter comparative study of the in vitro activity of fleroxacin and other antimicrobial agents. Markowitz SM, Williams DS, Hanna CB, Parker JL, Pierce MA, Steele JC. Chemotherapy; 1995 Mar 22; 41(6):477-86. PubMed ID: 8529440 [Abstract] [Full Text] [Related]
13. [Effect of lomefloxacin on luminol-dependent chemiluminescence and adhesion of leukocytes]. Iordanova AI, Nikitin AV. Antibiot Khimioter; 1996 Jan 22; 41(1):3-6. PubMed ID: 8762817 [Abstract] [Full Text] [Related]
14. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC. Deguchi T, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Fukuda H, Maeda S, Saito I, Kawada Y. Chemotherapy; 1997 Jan 22; 43(4):239-44. PubMed ID: 9209780 [Abstract] [Full Text] [Related]
15. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens. Naber KG, Well M, Hollauer K, Kirchbauer D, Witte W. Chemotherapy; 1998 Jan 22; 44(2):77-84. PubMed ID: 9551236 [Abstract] [Full Text] [Related]
17. Comparative in vitro activity of fleroxacin, two other quinolones and three board-spectrum beta-lactams using the E-Test. Sobottka I, Neumann S, Laufs R. Chemotherapy; 1994 Jan 22; 40(5):293-8. PubMed ID: 7956451 [Abstract] [Full Text] [Related]